We are pioneering approaches for building entirely synthetic genomes & for reprogramming the genetic code of living organisms for programmable polymer synthesis
Our CSO and founder has been selected to receive the Heinrich Wieland Prize from the Boehringer Ingelheim Stiftung for the groundbreaking research that underpins our company. constructive.bio/news/jason_…
As the market for GLP-1 agonists booms, The Observer UK explains how Constructive Bio has created a cleaner, more sustainable and efficient route to manufacturing the peptides. observer.co.uk/news/national…
Ready to explore non-canonical building blocks in proteins and peptides for cutting-edge results?
Our new explainer breaks it down in 90 seconds: from chaos to clarity 🚀
Boston-based serial entrepreneur & synthetic biology pioneer Rahul K Dhanda joins our BoD as NED. Rahul will deliver diverse expertise in platform development, strategic partnering, commercialisation & company-building, complementing the current team.
tinyurl.com/yc2f5a6a
Paul Wallace joins Constructive with 25+ years of international Business Development experience, commercialising innovative platforms and therapeutics. Together we will accelerate commercialisation of our ground-breaking genome reprogramming technology
tinyurl.com/yc2f5a6a
In a @TEDTalks Prof Jason Chin, the scientific brain behind @BioConstructiv, describes the rewriting of the genetic blueprint of cells to create a virus-resistant organism - the largest synthetic genome ever made!
Click here to listen:
ted.com/talks/jason_w_chin_a…
Constructive bio launches with $15m seed investment to re-engineer biology, creating new classes of enzymes, pharmaceuticals and biomaterials cambridgenetwork.co.uk/news/…